Article

Discovery of Simple Blood-Based Test to Predict Early Onset of Alzheimer’s Using Standard Clinical Mass Spectrometry Platforms

2021-01-26

Abstract excerpt

Despite the increasing number of individuals affected by Alzheimer’s disease (AD) every year, no effective therapy has been developed to treat this neurodegenerative disease yet. The current methods for AD diagnosis are effective for clinical confirmation of the disease only when symptoms become apparent, years after molecular damage started within the patients’ brains. As higher expression of a confor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6f9ef429-653a-5cd3-817b-5a27a8ee8abc
DOI: 10.20944/preprints202101.0530.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Discovery of Simple Blood-Based Test to Predict Early Onset of Alzheimer’s Using Standard Clinical Mass Spectrometry PlatformsDOI 10.20944/preprints202101.0530.v1Read

Performance of a Non-Invasive Blood Test for a Conformational Variant of p53 to Predict Alzheimer’s Disease Within 6 Years of Clinical DiagnosisSemantic proximity Read

A conformational variant of p53 (U-p53<sup>AZ</sup>) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s diseaseSemantic proximity Read

A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer's DiseaseSemantic proximity Read

Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma ProteomicsSemantic proximity Read

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read

Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseasesSemantic proximity Read

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity Read

Alzheimer’s disease: diagnostics, prognostics and the road to preventionSemantic proximity Read

Amyloid blood biomarker detects Alzheimer's diseaseSemantic proximity Read

Predicting Amyloid Positivity Through Proteomic and Machine Learning ApproachesSemantic proximity Read

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer’s disease: sequence and timingSemantic proximity Read

Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human SeraSemantic proximity Read